88(Thailand) Public Company LimitedSET: 88TH🇹🇭 TH

Internal Control · 2025

Internal Control — Board Opinion

Summary of the Board's Opinion on Internal Control

The Board of Directors recognizes the importance of having a sound internal control system and considers it a crucial duty to ensure that both the Company and its subsidiaries have appropriate and sufficient internal control and internal control review systems to oversee operations in compliance with objectives, goals, strategies, as well as relevant laws and regulations. The Company has arranged for an overall internal control system review (Overview Audit). and Follow-Up Internal Control System Review to establish a robust internal control system and ensure that the organization's operations achieve its defined objectives.

At the Meeting of the Board of Directors No. 2/2569, held on 27 February 2026 comprising 3 Audit Committee members in attendance, The Board of Directors considered and assessed the adequacy of the Company's internal control system using the Securities and Exchange Commission's internal control system adequacy assessment form, by inquiring information from management across various aspects, covering 5 part, in accordance with the guidelines of the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), which consists of

1. Control Environment

2. Risk Assessment

3. Control Activities of Management

4. Information and Communication System

5. Monitoring Activities

Adequacy & Appropriateness of the Internal Control System

Internal Control Framework Used

FrameworkDetail
The Committee of Sponsoring Organizations of the Treadway Commission (COSO)

The Board of Directors is of the opinion that the Company and its subsidiaries have adequate and appropriate internal control systems. The Company has provided sufficient personnel to effectively implement these systems, enabling the Company's operations to adhere to good corporate governance principles. (Good Corporate Governance) and transparency. Furthermore, the Company has established a system for monitoring operations of the Company, to ensure that the Company's assets can be protected from misuse or unauthorized use by directors or executives, as well as having adequate control systems for transactions with potentially conflicting parties or related persons.

In addition, the Board of Directors has appointed an Audit Committee to review the internal control and operational systems of the Company, in coordination with internal auditors, external auditors, and the Company's management, ensures that the internal control system is continuously adequate and appropriate, and that the Company's operations comply with securities and exchange laws, Stock Exchange of Thailand regulations, rules, announcements, and laws related to the Company's business operations.

Furthermore, the Company has appointed Well Planning Solution Co., Ltd. to serve as the internal auditor for the Company and its subsidiaries, with Ms. Waraluk Limsukprasert as the primary person responsible for internal auditing of the Company and its subsidiaries, due to her independence and over 29 years of experience in internal auditing. Compliance with the internal control systems of the Company and its subsidiaries is regularly audited every quarter, including performance monitoring and reporting the audit results to the Audit Committee every quarter.

Internal Control Deficiencies

Introduction

The independent internal auditor's operations covered the assessment of internal control components (COSO), the assessment of risks from the organizational-level internal control system compared to internal control guidelines under the COSO framework (The Committee of Sponsoring Organizations of the Treadway Commission), which consists of 5 components, and the assessment of the adequacy of internal control systems for the Company, totaling 11 processes, and for its subsidiaries, totaling 11 processes, namely:

1. Organizational Level

2. Marketing and Sales Promotion

3. Sales and Collection of Payments

4. Procurement, Hiring, and Payment

5. Warehouse Management and Product Delivery

6. Human Resources Management

7. Accounting and Financial Management

8. Asset Management

9. General Controls in Information Technology Systems

10. Personal Data Protection Management

11. Risk Management

Based on the review of the internal control system, the Company has no outstanding issues and no additional matters were identified compared to the most recent review.

Number of Deficiencies

MetricCurrent YearPrevious YearTwo Years Ago
Total number of internal control system deficiencies (cases)000

Audit Committee & Auditor Observations

Audit Committee's Opinion Differs from the Board's

No

Auditor Has Observations on Internal Control

No

Opinion on the Head of Internal Audit

Head of Internal Audit

3160

Audit Committee's Opinion on the Head of Internal Audit

The Company appointed Well Planning Solution Co., Ltd. to serve as the internal auditor for the Company and its subsidiaries. Ms. Waraluk Limsukprasert is the primary person responsible for the internal audit of the Company and its subsidiaries, owing to her independence and over 29 years of experience in internal audit operations. Her qualifications, experience, expertise, relevant internal audit training courses, and understanding of the industry in which the Company operates were thoroughly considered, leading to the conclusion that she is highly suitable for this role.

Appointment, Discharge & Transfer of the Head of Internal Audit

Requires Audit Committee Approval

Yes

Description

The consideration and approval of the appointment, removal, or transfer of internal auditors must be approved by the Audit Committee. The qualifications of the Head of Internal Audit are specified in Appendix 3 Details of the Heads of the Internal Audit and Compliance Units.

Related Party Transactions

Introduction

Connected Persons and Nature of Relationship

In 2025, the Company had related persons as defined under the Notification of the Capital Market Supervisory Board No. TorJor. 21/2551 regarding rules for connected transactions. Details of the connected persons and a summary of their relationships are provided below.

Connected Persons / Entities

Relationship

1. DOD Biotech Public Company Limited

  • Mr. Lampun Puntanaprates holds 32.67% of the Company's shares. 1/

2. PCCA Laboratory Co., Ltd.

Note : 1/ Currently, Mr. Lampun Puntanaprates has transferred shares to Kiatnakin Phatra Asset Management Company Limited (For the purpose of compliance with Management of Partnership Stakes and Shares of Ministers Act, B.E. 2543 by Mr. Lampun Puntanaprates) totaling 40,000,000 shares, representing 18.82%, and MFC Asset Management Public Company Limited (For the purpose of compliance with Management of Partnership Stakes and Shares of Ministers Act, B.E. 2543 by Mr. Lampun Puntanaprates) totaling 29,428,000 shares, representing 13.85%, in compliance with the Ministerial Share and Partnership Management Act B.E. 2543.

The Company considers disclosing transactions made with individuals or entities that fall outside the definitions of connected persons and potentially conflicting persons. Such disclosures are made because these individuals are relatives of the Company's connected persons, ensuring transparency and fairness to all shareholders equally. The names and relationships are summarized in the table below.

Related Persons

of connected persons

Relationship

1. Mr. Teeraphop Isarabhakdi

  • Mr. Teeraphop Isarabhakdi is the brother-in-law (wife's brother) of Mr. Lampun Puntanaprates.

  • Mr. Teeraphop Isarabhakdi is a shareholder of the Company, holding 4.80%.

  • These do not fall under the definition of connected persons and potentially conflicting persons.

2. Mr. Teeraphat Isarabhakdi

  • Mr. Teeraphat Isarabhakdi is the brother-in-law (wife's brother) of Mr. Lampun Puntanaprates.

  • Mr. Teeraphat Isarabhakdi is a shareholder of the Company, holding 0.42%.

  • These do not fall under the definition of connected persons and potentially conflicting persons.

3. Ms. Renumas Isarabhakdi

  • Ms. Renumas Isarabhakdi is the sister-in-law (wife's sister) of Mr. Lumpun Puntanaprates.

  • Ms. Renumas Isarabhakdi is a shareholder of the Company, holding 4.80%.

  • These do not fall under the definition of connected persons and potentially conflicting persons.

Entities with directors or major shareholders

Are relatives of connected persons

Relationship

3. WL333 Co., Ltd.

  • Ms. Renumas Isarabhakdi is the sister-in-law (wife's sister) of Mr. Lumpun Puntanaprates.

  • Ms. Renumas Isarabhakdi, a shareholder of WL333 Co., Ltd., holding 70.00% since January 21, 2022.

  • These do not fall under the definition of connected persons and potentially conflicting persons.


Has Related Party Transactions

No

Policy & Future Trends

Policy, Measures & Approval Process

The Company has established policies and procedures for connected transactions between the Company and its subsidiaries with individuals or entities that may have conflicts of interest, to ensure transparency in transactions and to protect the interests of shareholders. These can be summarized as follows:

(1) In conducting inter-company transactions or connected transactions of the Company and its subsidiaries, the Board of Directors shall establish clear and transparent procedures for approving such transactions to prevent conflicts of interest for any party and to strictly comply with laws, principles, methods, and disclosure requirements for inter-company or connected transactions. This will be done through a screening process by the Audit Committee, prioritizing the Company's interests. The Board of Directors will ensure compliance with the relevant regulations, announcements, orders, and criteria of the Capital Market Supervisory Board, the SEC Office, and the Stock Exchange of Thailand, as well as consider the accurate and complete disclosure of inter-company or connected transaction information to the public.

(2) In considering the approval of inter-company transactions or connected transactions, the Company shall take into account the appropriateness of the price and the reasonableness of such transactions, by considering various terms and conditions to be in line with normal business practices in the industry, and/or compared with prices from third parties, and/or market prices, and/or have prices or terms of such transactions at the same level as third parties, and/or can demonstrate that such transactions have reasonable or fair prices or terms, and the Company will regularly monitor and oversee the transactions that occur.

(3) The Company may arrange for individuals with knowledge, expertise, and specialized skills, such as independent experts, auditors, or independent asset appraisers, to provide opinions on such inter-company transactions or connected transactions, for the consideration of the Audit Committee and/or the Board of Directors and/or the shareholders' meeting (as the case may be).

(4) The Company or its subsidiaries may conduct inter-company transactions and connected transactions with directors, executives, or related persons only when such transactions have been approved according to the criteria set by the Stock Exchange of Thailand and the SEC Office, and are transactions consistent with the policy.

The Company, unless it is a transaction that is a commercial agreement of the same nature as a prudent person would conduct with a general counterparty in the same situation, with commercial bargaining power free from the influence of their status as a director, executive, or related person, as the case may be, and is a commercial agreement approved by the Board of Directors or in accordance with principles already approved by the Board.

(5) Directors, executives, and employees of the Company should refrain from engaging in transactions that constitute inter-company transactions and connected transactions that may create a conflict of interest with the Company. Furthermore, all directors, executives, and employees have a duty to report any conflicts of interest related to the management of the Company's business, their own performance of duties, and those of related persons that may create a business conflict of interest with the Company, such as holding shares in businesses that compete with the Company's business, co-investing or having interests with business partners of the Company or its customers, holding any position or participating as an advisor to business partners of the Company or its customers, or selling goods or providing services to the Company, whether directly or indirectly.

(6) Directors, executives, and employees of the Company must not seek benefits for themselves or others by using confidential information of the Company, such as business plans, revenues, benefits, meeting resolutions, business forecasts, bidding prices, as well as other important Company information, regardless of whether such actions cause damage to the Company. Furthermore, all directors, executives, and employees of the Company must strictly adhere to the Company's insider trading policy.

(7) The Company shall prepare a summary report of inter-company transactions or connected transactions to be submitted to the Audit Committee meeting and the Board of Directors meeting for consideration every quarter.

(8) In considering the approval of connected transactions or transactions with major shareholders, directors, executives, or persons who may have a conflict of interest, or related persons of the Company, directors with a conflict of interest and/or directors who are related persons shall not attend the meeting and shall not have the right to vote on the approval of such transactions. This is to ensure that such transactions do not involve the transfer or diversion of the Company's benefits, but rather are transactions that prioritize the best interests of the Company and its shareholders.

(9) The Company has established policies for entering into transactions that are commercial agreements with general commercial terms and transactions that are commercial agreements not under general commercial terms, in accordance with the following principles:

(a) Transactions that are commercial agreements with general commercial terms

For connected transactions that are commercial agreements with general commercial terms between the Company and its subsidiaries and directors, executives, or related persons, once approved in principle by the Board of Directors, the management may approve such transactions if those transactions have commercial agreements of the same nature as a prudent person would conduct with a general counterparty in the same situation, with commercial bargaining power free from the influence of their status as a director, executive, or related person, under reasonable and verifiable terms, and do not result in the transfer of benefits, and/or can demonstrate that such transactions have reasonable and fair prices and terms, and are commercial agreements approved by the Board of Directors or in accordance with principles already approved by the Board of Directors.

(b) Connected transactions that are not commercial agreements with general commercial terms

For connected transactions that are commercial agreements not under general commercial terms, the Company shall arrange for the Audit Committee to review and provide opinions on the necessity and reasonableness of such transactions, considering fair and reasonable prices and terms that are consistent with normal business practices in the industry, and/or compared with prices from third parties, and/or market prices, and/or have prices or terms of transactions at the same level as third parties, and/or can demonstrate that such transactions have reasonable or fair prices or terms, before the Company seeks approval for such transactions from the Board of Directors and/or the shareholders' meeting (as the case may be). Furthermore, the Company shall comply with the Securities and Exchange Act, regulations, announcements, orders, requirements, or criteria of the Capital Market Supervisory Board, the SEC Office, and the Stock Exchange of Thailand, including compliance with requirements regarding the disclosure of connected transaction information and other relevant criteria.

(10) In cases where the Audit Committee lacks expertise in considering potential connected transactions, the Company may engage individuals with specialized knowledge, such as auditors, asset appraisers, law firms, etc., who are independent from the Company and related persons, to provide opinions on such connected transactions. These opinions will be used to support the decision-making of the Audit Committee and/or the Board of Directors and/or shareholders, as the case may be, to ensure that such transactions are necessary and reasonable, taking into account the Company's best interests.

Policy for Future Connected Transactions

For connected transactions that may occur in the future, the Board of Directors shall proceed as follows:

(a) The Company shall comply with the Securities and Exchange Act and the regulations, announcements, orders, or requirements of the Capital Market Supervisory Board and the Stock Exchange of Thailand. Such transactions must not involve the transfer or diversion of benefits between the Company or its shareholders, but must be transactions where the Company has prioritized the best interests of the Company and all shareholders.

(b) In the case of transactions that occur normally or support normal business operations and are expected to continue in the future, the Company shall proceed according to the principles and guidelines for general commercial practices, referencing appropriate, fair, and reasonable prices and terms that are verifiable. Such transactions shall comply with the principles regarding agreements with general commercial terms as approved by the Board of Directors' meeting. In this regard, the management shall prepare a summary of such transactions to report at the Audit Committee meeting every quarter, for the purpose of preparing the annual information statement (56-1 One Report).

(c) The disclosure of inter-company transactions or connected transactions of the Company must comply with the laws and regulations prescribed by the SEC Office and the Stock Exchange of Thailand, as well as accounting standards related to related companies or persons issued by the Federation of Accounting Professions.

Contents